Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Location: United States, California, San Francisco
Total raised: $70M
Investors 3
| Date | Name | Website |
| - | New Enterp... | nea.com |
| - | F-Prime Ca... | fprimecapi... |
| - | Eight Road... | eightroads... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.03.2018 | Series B | $70M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 29.03.2021 | Tempest Therapeutics jumps onto Nasdaq in merger with... | Less than a month after landing a Big Pharma partner on one of its lead oncology programs, T... | endpts.com... |
| 30.03.2018 | Term Sheet — Friday, March 30 | HEALTHCARE WARS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see... | fortune.co... |
| 29.03.2018 | Tempest Therapeutics Closes $70M Series B Financing | Tempest Therapeutics, Inc., a San Francisco, CA-based development-stage biotechnology company advanc... | finsmes.co... |
| 29.03.2018 | Tempest Therapeutics Raises $70M | SAN FRANCISCO, CA, Tempest Therapeutics today announced the completion of a $70 million Series B f... | vcnewsdail... |
| 28.03.2018 | Tempest Therapeutics Closes $70 Million Series B Financing | - | fprimecapi... |